Acquisitions8 Jan 2024, 11:10 pm
Cipla Announces Joint Venture for Cell Therapy Products in the US
AI Summary
Cipla Limited has announced a strategic collaboration with Kemwell Biopharma and Manipal Education & Medical Group to develop and commercialize novel Cell therapy products for major unmet medical needs in the US, Japan, and EU regions. Cipla will secure a 35.2% stake in the joint venture company.,
Key Highlights
- Cipla announces joint venture for Cell therapy products in the US
- Kemwell Biopharma and Manipal Education & Medical Group to collaborate
- Primary goal is to develop and commercialize novel Cell therapy products for major unmet medical needs
- Cipla to secure 35.2% stake in the joint venture company